Genesis Healthcare

Machine learning (ML) algorithms are increasingly used to predict outcomes in orthopaedic surgery, but their utility in hip arthroscopy remains unclear. This study aimed to (1) evaluate ML models for predicting outcomes, complications, and resource use following hip arthroscopy, (2) compare ML performance to traditional statistical methods, and (3) critically appraise the quality of existing literature. A systematic search of PUBMED, MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials was conducted on 4 April 2023. Included studies used ML models for clinical prediction in hip arthroscopy. Data on study design, outcomes, model development, validation and adherence to TRIPOD guidelines were extracted. Seventeen studies involving 37,549 patients (52.8% female; mean age 34.4 ± 6.1 years) were included. ML was used to predict clinical outcomes (47.1%), adverse events (47.1%) and resource utilisation (5.9%). The median area under the curve was 0.66 (range 0.5-0.94) for clinical outcomes and 0.7 (range 0.6-0.9) for adverse events. Resource utilisation was reported with a root-mean-square error of $3800, a logarithmic error of 0.2, and R² of 0.8. Only four studies compared ML to traditional regression; two found no difference, while two favoured ML. On average, studies met 12.3 of the 22 TRIPOD criteria, with only 29.4% meeting more than two-thirds. ML models in hip arthroscopy show variable performance in predicting outcomes and complications. Furthermore, most studies comparing ML models to traditional regression did not report any significant difference. Lastly, variability in adherence to TRIPOD guidelines highlights the need for future studies to improve transparency and reporting in the development of ML algorithms for hip arthroscopy. Given the potential of ML models in enhancing clinical decision-making for hip arthroscopy, along with the findings of the current study, their application should be used with caution. Level IV, systematic review of level II-IV studies.

This report describes an 8-day-old foal diagnosed with acute respiratory distress syndrome (ARDS) successfully managed using a novel approach of intratracheal oxygen delivery. An 8-day-old Standardbred filly presented for an acute onset of respiratory distress. Given the acute onset, known risk factors, bilateral diffuse infiltrate on thoracic radiographs, and low PaO2:FiO2 ratio of 170.5, the foal was diagnosed with acute respiratory distress syndrome. Initial treatment consisted of antimicrobial therapy (minocycline and metronidazole), nonsteroidal anti-inflammatories (flunixin meglumine), and intranasal oxygen. The filly responded poorly to intranasal oxygen therapy and clinically worsened in hospital, with poor response confirmed on arterial blood gas. Treatment was transitioned to intratracheal therapy via temporary tracheostomy to improve the FiO2 delivered to the foal. After 24 h of therapy, the arterial oxygen saturation improved to 96.8% and PaO2 improved to 154.1mm Hg. The foal was able to avoid constant sedation, intubation, and mechanical ventilation with the use of a temporary tracheostomy. A blood culture was negative, and no transtracheal wash was performed; thus, the underlying etiology is unknown. Oxygen therapy was able to be discontinued on the seventh day of hospitalization, and on the 12th day, the foal was discharged with continued antimicrobial treatment. No complications were associated with placement of the temporary tracheostomy. Five months after discharge, the foal continues to do well at home. This case supports the use of intratracheal oxygen therapy via temporary tracheostomy for the treatment of acute respiratory distress syndrome compared with previous reports of catheterization to improve oxygen delivery. Further investigation is warranted to determine the peak FiO2 able to be delivered via temporary tracheostomy.

Fluid and electrolyte therapy are key components to successful management of ill horses and foals. Despite this, there is little evidence-based treatment recommendations with regards to type and rate of fluid administration in horses and foals. This chapter reviews pertinent normal water and electrolyte balance in horses and foals, how to assess a patient with regards to employing and modifying fluid therapy, and developing a fluid therapy plan including when to consider additives for adults and foals.

BackgroundThe gut microbiome may influence breast cancer (BC) development by modulating estrogen metabolism, immune responses, and microbial metabolites. Altered microbial patterns have been reported in BC, but their value as predictive biomarkers remains uncertain.MethodsWe reviewed 13 case–control studies that compared gut microbiome composition in women with and without BC, focusing on diversity, compositional shifts, and geographic variation.ResultsReduced microbial richness (alpha diversity, the number and balance of bacterial species) was observed in more than half of the studies, although findings were not uniform. Differences in community composition (beta diversity) were common. Across studies, BC was consistently associated with elevated Bacteroides and reduced Faecalibacterium, a genus linked to anti-inflammatory effects. Other recurrent findings included enrichment of Eggerthella and Blautia in BC, though results for several taxa were inconsistent. Geographic variation was evident: Eggerthella was enriched in U.S. cohorts, Blautia in European cohorts, and in Chinese cohorts, Prevotella was elevated while Akkermansia was reduced.ConclusionsDespite heterogeneity, converging evidence supports reduced diversity and shifts in select taxa, particularly enrichment of Bacteroides and depletion of Faecalibacterium, as emerging features of the BC microbiome. Geographic differences underscore the influence of host and environmental factors. These findings suggest biomarker potential but highlight the need for larger, longitudinal, and standardized studies to establish causality and clinical utility.

As the UK advances toward net zero, it faces the critical challenge of balancing the competing demands for secure, affordable, and low-carbon energy. Yet, with only 12 days of gas storage capacity - compared to 90 in Germany, more than 100 in France, 123 in the Netherlands, and up to 150 days in Italy - the UK remains exposed to supply disruptions and price volatility. The Bains project, a depleted natural gas reservoir in the East Irish Sea Basin, is being developed into an underground natural gas storage (UGS) facility. Once operational, it will increase the UK's gas storage capacity by up to 50%, significantly strengthening energy security. Looking ahead, the project also aligns with the UK's decarbonisation goals by offering the potential for future large-scale hydrogen storage, a critical enabler of the hydrogen economy. A key challenge in developing such infrastru

Abstract This paper provides a comprehensive analysis of the carbon capture and storage value chain, focusing on cost optimization strategies and frameworks for successful development. Through systematic evaluation of capture-transport-storage components, we identify critical cost drivers and demonstrate methodologies for economic optimization in early-stage project development. Carbon capture technologies constitute the primary cost component, accounting for 60-80% of total chain (IEA 2024), with post-combustion systems exhibiting energy penalties of 25-35% compared to 15-20% for advanced solvents (Environmental Science & Technology 2024). Transportation costs range from 0.25-55.82 euros per tonne depending on distance and flowrate, while storage costs demonstrate significant variability based on geological conditions and monitoring requirements (MDPI 2024). Cost optimization analysis confirms that cluster and hub models achieve 30-40% cost reductions compared to standalone facilities when maintaining utilization rates above 80% (World Economic Forum 2025). The Northern Lights and Porthos projects early implementation results provide encouraging indicators of successful multi-stakeholder collaboration approaches (Equinor. 2024; Port of Rotterdam. 2024). Digital cost estimation methodologies enable progressive accuracy improvement until final investment decision, supporting systematic project optimization throughout development phases.

Abstract This study evaluates the survivability assessment methodologies for semi-submersible Floating Offshore Wind Turbines (FOWTs) against capsizing and sinking risks. Current industry standards employ conservative stability criteria derived from offshore and marine practices, potentially leading to over-designed structures despite FOWTs’ lower risk profile as unmanned facilities. Through a case study of a three-column semi-submersible FOWT stationed with 9 mooring lines, this research compares two stability assessment approaches: the traditional area-ratio-based method and the dynamic-response-based criterion. Results from comprehensive stability analyses show that while the semi-submersible marginally satisfies the area-ratio-based survivability requirement with a ratio of 1.31 (versus required 1.30), it demonstrates substantially higher resistance to capsizing and sinking under dynamic-response-based assessment, achieving a ratio of 2.99 (versus required 0.10). These findings indicate that current survivability assessment by area-ratio method may be overly conservative in evaluating FOWTs’ resistance to capsizing and sinking. The adoption of dynamic-response-based survivability assessment methodologies could enable more accurate evaluation of semi-submersible FOWTs’ resistance to capsizing and sinking, potentially leading to optimized designs that maintain adequate survivability while reducing structural costs—a critical factor in enhancing the economic viability of floating offshore wind energy development.